Eksempel: Heart Attack

Søg i kliniske forsøg efter: Clofibric Acid

I alt 30 resultater

NCT01527318

Afsluttet

The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)

Betingelser: Neutral Lipid Storage Disease
NCT03586674

Afsluttet

Fibrates in Pediatric Cholestasis

Betingelser: Chronic Cholestasis
NCT00491400

Afsluttet

Effect of a Fibrate and a Statin on Endothelial Dysfunction

Betingelser: Diabetes Mellitus; Metabolic Syndrome
NCT00243672

Trukket tilbage

Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques

Betingelser: Atherosclerosis
NCT03110432

Rekruttering

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Betingelser: Dyslipoproteinemias
NCT02530827

Afsluttet

Energy Expenditure of People Living With HIV/AIDS

Betingelser: HIV/AIDS; HIV Lipodystrophy Syndrome
NCT04140201

Ikke rekrutteret endnu

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

Betingelser: Diabetic Retinopathy
NCT00156169

Afsluttet

The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.

Betingelser: Low HDL Cholesterol
NCT01674712

Afsluttet

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Betingelser: Dyslipidemia
NCT00934219

Ukendt status

Triglyceride Lowering Study

Betingelser: Hypertriglyceridemia
NCT01101503

Ukendt status

The Effect of Intensive Multifactorial Therapy on Endothelial Function in Newly Diagnosed Type 2 Diabetes

Betingelser: Endothelial Dysfunction
NCT03649269

Afsluttet

PC-300 Tea Effect on Triglyceride Levels

Betingelser: Hypertriglyceridemia
NCT02965911

Ukendt status

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

Betingelser: Primary Biliary Cirrhosis
NCT00535925

Afsluttet

Nephropathy In Type 2 Diabetes and Cardio-renal Events

Betingelser: Diabetic Nephropathy
NCT04436419

Afsluttet

Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study

Betingelser: Obesity; Obesity, Abdominal; Obesity, Visceral; Female
NCT00728910

Afsluttet

Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study

Betingelser: Dyslipidemia
NCT04309773

Ikke rekrutteret endnu

Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

Betingelser: Primary Sclerosing Cholangitis; Cholestasis
NCT00542178

Afsluttet

Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

Betingelser: Diabetic Retinopathy
NCT03856632

Rekruttering

Liraglutide Effect in Atrial Fibrillation

Betingelser: Atrial Fibrillation
NCT03323788

Ukendt status

PGC-1 & MUSCLE MITOCHONDRIAL DYSFUNCTION IN DIABETES: AIMS 1-4

Betingelser: Type2 Diabetes; Obesity
NCT02886299

Afsluttet

Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis

Betingelser: Fenofibrate/Simvastatin Comparison
NCT00458055

Afsluttet

High-Density Lipoprotein (HDL) Treatment Study

Betingelser: Coronary Arteriosclerosis; Hypoalphalipoproteinemias; Genetic Diseases, Inborn
NCT00309712

Afsluttet

Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

Betingelser: Type II Diabetes Mellitus; Mixed Dyslipidemia
NCT03430284

Rekruttering

Multifactorial Intervention on Diabetes (MIDiab Study)

Betingelser: Diabetes Mellitus, Type 2
NCT02282423

Afsluttet

PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes

Betingelser: Diabetes; Obesity